相关实验视频
Updated: Jan 14, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
怀孕期间的肥胖:当代证据和临床影响
1Kokilaben Dhirubhai Ambani Hospital.
怀孕期间的孕产妇肥胖对母亲和婴儿构成风险. 有效的管理包括怀孕前,产前和产后护理,包括生活方式的改变和代谢监测.
科学领域:
- 生殖健康 生殖健康
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 孕产妇肥胖是一个重要的全球健康问题.
- 它会影响母亲,胎儿和后代的健康状况.
- 了解它的机制和风险至关重要.
研究的目的:
- 审查孕期孕产妇肥胖的病理生理机制.
- 为了突出与妊娠肥胖相关的临床风险.
- 概述基于证据的整个妊娠连续性的管理策略.
主要方法:
- 这是一个复习文章.
- 它综合了关于孕期孕产妇肥胖的当前知识.
- 专注于怀孕前期,产前期和产后期.
主要成果:
- 孕产妇的肥胖会加剧胰岛素抵抗,炎症和荷尔蒙失衡.
- 相关风险包括妊娠糖尿病,高血压疾病和宏观性.
- 胎儿代谢编程会增加后代患肥胖和2型糖尿病的风险.
结论:
- 综合护理对于管理妊娠肥胖是必不可少的.
- 预孕,产前和产后干预改善了结果.
- 多学科,文化敏感的策略是跨代健康的关键.
更多相关视频
11:44A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
Published on: September 27, 2017
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
相关概念视频
Obesity
Drug Dosing: Obese Patients
Diabetes Mellitus: Type 2 and Gestational
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion